Stay updated on Pembrolizumab vs Ipilimumab in Melanoma Clinical Trial

Sign up to get notified when there's something new on the Pembrolizumab vs Ipilimumab in Melanoma Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Pembrolizumab vs Ipilimumab in Melanoma Clinical Trial page

  1. Check
    yesterday
    No Change Detected
  2. Check
    8 days ago
    Change Detected
    Summary
    The study page no longer shows the Melanoma label and the related topics section with MedlinePlus Genetics, reducing disease-specific context and linked resources.
    Difference
    0.2%
    Check dated 2026-07-11T00:07:47.000Z thumbnail image
  3. Check
    15 days ago
    Change Detected
    Summary
    Revision tag updated from v3.6.2 to v3.6.3, signaling a minor backend update. No study details or displayed information appear to be affected.
    Difference
    0.1%
    Check dated 2026-07-03T22:25:05.000Z thumbnail image
  4. Check
    22 days ago
    Change Detected
    Summary
    The page now shows revision v3.6.2, replacing the previous v3.6.0. This reflects a newer document version rather than changes to study data or content.
    Difference
    0.1%
    Check dated 2026-06-26T23:55:35.000Z thumbnail image
  5. Check
    36 days ago
    Change Detected
    Summary
    Recruitment status updated to indicate no more participants are being sought. New help and navigation sections were added (How to Read a Study Record, Common Questions, How to Join a Study), and the revision tag was updated from v3.5.5 to v3.6.0.
    Difference
    0.4%
    Check dated 2026-06-12T16:15:57.000Z thumbnail image
  6. Check
    43 days ago
    Change Detected
    Summary
    The page adds a Melanoma topic tag and related topics including MedlinePlus Genetics, and updates the site revision from v3.5.4 to v3.5.5.
    Difference
    0.2%
    Check dated 2026-06-05T11:34:55.000Z thumbnail image
  7. Check
    51 days ago
    Change Detected
    Summary
    The Melanoma keyword tag and the related topics section including MedlinePlus Genetics have been removed, reducing cross-links to related topics on the study page.
    Difference
    0.2%
    Check dated 2026-05-29T07:38:55.000Z thumbnail image

Stay in the know with updates to Pembrolizumab vs Ipilimumab in Melanoma Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Pembrolizumab vs Ipilimumab in Melanoma Clinical Trial page.